ArticleOpen forum infectious diseases2022

Single-Dose, Patient-Initiated Amenamevir Therapy for Recurrent Genital Herpes: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.

Makoto Kawashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.